Publication Details
Publisher: BioScience Academic Publishing
Issue: Vol 3, No 10 (2026)
ISSN: 2997-7185

Abstract

Background; Infertility is a significant health concern affecting many women in Mosul City. Hysterosalpingography (HSG), a diagnostic and potentially therapeutic procedure, may increase the likelihood of pregnancy in infertile females by identifying and sometimes resolving tubal blockages. Aims of the study; To evaluate the incidence of pregnancy in infertile females following hysterosalpingography (HSG) and assess its potential therapeutic effect in patients attending medical facilities in Mosul City. Methods; A total of 130 infertile females underwent hysterosalpingography (HSG) between days 6–9 of their menstrual cycle. The procedure involved fluoroscopic imaging using Biemexol (Iohexol 35 mg/ml) to assess uterine shape and tubal patency. Patients were positioned lithotomy- positon, and contrast was injected via catheter. Real-time imaging monitored contrast flow into the peritoneal cavity. Contraindications included pregnancy, pelvic infection, or iodine allergy. Antihistamines were used in patients with mild contrast allergies to reduce adverse reactions. Results; The study included women with a mean age of 30.49 years and a mean pregnancy delay of 4.13 months. Most had normal fallopian tubes (65.6%), while 32.9% showed some form of blockage. The pregnancy rate post-HSG was 51.9%. Additionally, 31.3% had a history of pelvic surgery and 31.3% had experienced pelvic inflammatory disease (PID). These findings suggest tubal abnormalities, surgical history, and PID may significantly impact fertility and pregnancy outcomes among the participants. Conclusions; HSG may improve pregnancy rates in infertile women by clearing minor tubal blockages or adhesions. The high incidence of tubal abnormalities and history of pelvic infections or surgeries suggests these factors play a key role in delayed conception.

Keywords
Infertility Hysterosalpingography (HSG) Fallopian Tube Blockage Pelvic Inflammatory Disease (PID) Tubal Patency